Trial Profile
Prospective, Open-labelled, Phase II Study, of the Administration of Desmopressin in Patients With Colorectal Cancer, With or Without Metastasis, With Rectal Bleeding, Before Treatment With Surgery and/or Chemotherapy and/or Radiotherapy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Desmopressin (Primary)
- Indications Adenocarcinoma; Colorectal cancer; Haemostatic disorders; Rectal bleeding
- Focus Adverse reactions; Therapeutic Use
- Sponsors Elea
- 12 Mar 2020 Results published in the Investigational New Drugs
- 23 Aug 2017 Status changed from recruiting to completed.
- 05 Jun 2017 Planned End Date changed from 1 Mar 2017 to 1 Aug 2017.